Dihydroergotoxine Methanesulfonate Injection

Functions and indications: Insufficient blood supply to the brain, acute ischemic stroke, sequelae of stroke or brain trauma, and senile dementia. Peripheral vascular disease (vascular thrombotic vasculitis, Raynaud’s disease, cyanosis of hands and feet, functional disorders caused by arteriosclerosis and diabetes), cervical syndrome, vascular cochlear vestibular syndrome, vascular retinopathy. Vascular migraine and other headaches, hypertension.
Adverse reactions:
Usually well tolerated, occasional digestive tract disorders: nausea, vomiting, abdominal distension, anorexia; blurred vision; nasal congestion and rash. There is no need to stop the drug if the above phenomena occur, and adverse reactions can usually be avoided by reducing the dose.
Contraindications:
People who are allergic to this product, patients with vascular diseases, arteritis, coronary heart disease, severe liver damage, and sepsis are prohibited. Pregnant and lactating patients are prohibited.